This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
4 HMO Stocks in Focus Despite Tech Costs, Nursing Shortage
by Debasmita Chatterjee
A well-performing government business might aid the Medical-HMO industry. However, expenses incurred for technology advancements and a shortage of nurses will dampen margins. Stocks like UNH, CI, HUM and CNC are likely to ride out the industry storms.
Humana (HUM) Stock Moves -0.97%: What You Should Know
by Zacks Equity Research
Humana (HUM) closed the most recent trading day at $503.53, moving -0.97% from the previous trading session.
Why Humana (HUM) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Humana (HUM) Stock Moves -0.3%: What You Should Know
by Zacks Equity Research
In the latest trading session, Humana (HUM) closed at $521.51, marking a -0.3% move from the previous day.
Humana (HUM) Rises 23% in Past 6 Months: More Room to Run?
by Zacks Equity Research
Humana (HUM) is well-poised for growth on improving revenues, numerous contract wins and adequate cash-generating abilities.
Humana (HUM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Humana (HUM) closed at $547.36, marking a -0.33% move from the previous day.
Humana (HUM) Down 2.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Humana (HUM) Ups '23 Medicare Advantage Membership Growth View
by Zacks Equity Research
Humana (HUM) expects 2023 net membership gains to be a minimum of 10.9% from the 2022 projection.
Humana (HUM) Issues $1.25B Senior Notes, To Lower Debt Level
by Zacks Equity Research
Humana (HUM) issues senior notes with the intent to procure funds to trim its escalating debt level.
Humana's (HUM) Arm to Aid Senior Care, 2023 Expansion on Track
by Zacks Equity Research
Humana's (HUM) CenterWell brand plans to open centers in untapped markets as well as dig deeper into the existing regions offering enhanced primary care services to the nation's senior citizens.
Why Humana (HUM) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Analyst Blog Highlights Amazon, Sanofi, Target, Humana and PNC Financial Services
by Zacks Equity Research
Amazon, Sanofi, Target, Humana and PNC Financial Services are included in this Analyst Blog.
Top Stock Reports for Amazon.com, Sanofi & Target
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Sanofi (SNY) and Target Corporation (TGT).
October CPI Data Raises Hope for a Soft Landing: 5 Top Picks
by Nalak Das
We have narrowed our search to five U.S. corporate behemoths with solid growth potential. These are: HUM, MPC, CAT, MCK and ORLY.
Why Acadia Healthcare (ACHC) Lost 3% Since Q3 Earnings Release
by Zacks Equity Research
Acadia Healthcare's (ACHC) third-quarter results reflect escalating salaries, wages and benefits. The downside was partly mitigated by rising patient admissions within its U.S. facilities.
Zacks.com featured highlights Kroger, Halliburton, Humana, Associated Banc-Corp and Pure Storage
by Zacks Equity Research
Kroger, Halliburton, Humana, Associated Banc-Corp and Pure Storage have been highlighted in this Screen of The Week article.
5 Stocks With Upgraded Broker Ratings to Fight Recession Risk
by Swayta Shah
As brokers have a deeper insight into stocks, one must follow rating upgrades before investing. We pick Kroger (KR), Halliburton (HAL), Humana (HUM), Associated Banc-Corp (ASB) and Pure Storage (PSTG), as these have seen rating upgrades recently.
Tenet Healthcare (THC) Q3 Earnings Beat, Down Y/Y, Shares Drop
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results reflect a dismal performance of the Hospital Operations and Other segment as well as continued pressure on patient volumes from the pandemic.
Company News for Nov 3, 2022
by Zacks Equity Research
Companies In The News Are: CVS, HUM, ETR, NVO.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit
by Zacks Equity Research
Humana's (HUM) third-quarter earnings gain from solid premiums and membership growth within its individual Medicare Advantage business coupled with a well-performing Healthcare Services segment.
Humana (HUM) Tops Q3 Earnings Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 10.08% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Humana Q3 Preview: Can The Earnings Streak Continue?
by Derek Lewis
Humana has an impressive earnings track record, exceeding the Zacks Consensus EPS Estimate in each quarter dating all the way back to 2016.
Can Humana (HUM) Sustain Its Earnings Beat Streak in Q3?
by Zacks Equity Research
Humana's (HUM) Q3 results are expected to reflect growing premiums, attributable to its Medicare Advantage and Medicaid businesses. However, elevated marketing costs might have strained its margins.
Humana and Zoom Video have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Humana and Zoom Video are part of the Zacks Bull and Bear of the Day article.